Madeline Kirkpatrick

Madeline Kirkpatrick

Auto-generated profile, based on publicly available information

Madeline Kirkpatrick

Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, King's College London, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MKMadeline Kirkpatrick
Madeline Kirkpatrick
GMGargi Mandal
Gargi Mandal
IEIsmail Elhadidy
Ismail Elhadidy
NMNicole Mariani
Nicole Mariani
KPKristi Priestley
Kristi Priestley
ABAlessandra Borsini
Alessandra Borsini
Background: Depression in pregnancy can increase vulnerability for psychiatric disorders in the offspring, likely via the transfer of heightened maternal cortisol and cytokines to the in-utero environment. However, the precise cellular and molecular mechanisms, are largely unclear. Animal studies can represent this complex pathophysiology at a systemic level but are expensive and ethically challenging. While simpler, in vitro models offer high-throughput opportunities. Therefore, this systematic review integrates findings of in vitro models relevant to depression in pregnancy, to generate novel hypotheses and targets for intervention. Methods: The systematic analysis covered studies investigating glucocorticoid or cytokine challenges on placental or foetal neural progenitor cells (NPCs), with or without co-treatment with sex hormones. Results: Of the 50 included studies, 11 used placental cells and 39 NPCs; surprisingly, only one used a combination of oestrogen and cortisol, and no study combined placental cells and NPCs. In placental cells, cortisol or cytokines decreased nutrient transporter expression and steroidogenic enzyme activity, and increased cytokine production. NPCs exhibited decreases in proliferation and differentiation, via specific molecular pathways, namely, inhibition of hedgehog signalling and activation of kynurenine pathway. In these cells, studies also highlighted epigenetic priming of stress and inflammatory pathways. Conclusions: Overall, results suggest that stress and inflammation not only detrimentally impact placental regulation of nutrients and hormones to the foetus, but also activate downstream pathways through increased inflammation in the placenta, ultimately eliciting adverse effects on foetal neurogenesis. Future research should investigate how sex hormones regulate these mechanisms, with the aim of developing targeted therapeutic approaches for depression in pregnancy.

16 July 2025 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
GMGargi Mandal
Gargi Mandal
Silvia AlboniSilvia Alboni
Silvia Alboni
NCNadia Cattane
Nadia Cattane
MMMoira Marizzoni
Moira Marizzoni
SSSamantha Saleri
Samantha Saleri
ABAlessandra Borsini
Alessandra Borsini
The dietary ligands, omega-3 fatty acid endocannabinoids (eCBs) eicosapentaenoyl ethanolamide (EPEA) and docosahexaenoyl ethanolamide (DHEA), and short-chain fatty acids (SCFAs) acetate, propionate and butyrate, have anti-inflammatory and antidepressant properties. However, the molecular mechanisms underlying their action in the human brain remain elusive. Here, we treated human hippocampal neurons (HPC0A07/03 C) with eCBs (EPEA (300 pM) or DHEA (700 pM)), or SCFAs (acetate (200 uM), propionate (30 uM), butyrate (20 uM)), followed by interleukin (IL)1β (10,000 pg/ml) or IL6 (50 pg/ml). We found that treatment with either eCBs or SCFAs prevented IL1β- and IL6-induced reduction in neurogenesis and increase in apoptosis. These effects were mediated by IL1β-induced production of IL6, interferon-gamma (IFNγ) and tumour necrosis factor-alpha (TNFα), and by IL6-induced IL1β, IL8 and IL13, all of which were prevented by treatment with eCBs. In contrast, IL1β-induced production of IL6, IL12 and fractalkine (CX3CL1), and IL6-induced production of CX3CL1, were prevented by SCFAs. Treatment with IL1β and IL6 also increased the production of candidate kynurenine pathway metabolites, such as kynurenine (KYN) and nicotinic acid (NICA), which again were prevented by eCBs and SCFAs. We then conducted mRNA sequencing analysis to investigate cellular genes and signalling pathways relevant for the neuro-inflammatory changes previously observed, and putatively prevented by eCB and SCFA treatment. We found that IL1β decreased the expression of the neuroplasticity gene, FRY microtubule binding gene (FRY), and increased the expression of the neuroinflammation gene, U3 small nucleolar ribonucleoprotein homolog C subunit processome component (UTP14C), and both these effects were prevented by either acetate or propionate. Similarly, the expression of the proinflammatory gene, ADAM metallopeptidase with thrombospondin type 1 motif 1 (ADAMTS1), was increased by IL6, an effect that was prevented by either EPEA or acetate. Altogether, we identify novel anti-inflammatory and neurogenic mechanisms mediating the effect of eCBs and SCFAs on human hippocampal neurogenesis, which can be significant as potential future treatment candidates in the context of neuropsychiatric disorders.

12 April 2026 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
MKMadeline Kirkpatrick
Madeline Kirkpatrick
KPKristi Priestley
Kristi Priestley
RBRebecca H. Bind
Rebecca H. Bind
LRLavinia Rebecchini
Lavinia Rebecchini
ABAlessandra Borsini
Alessandra Borsini
CPCarmine Pariante
Carmine Pariante
The arts, specifically music interventions, have emerged as a promising therapeutic strategy for postnatal depression (PND). The Scaling-up Health-Arts Programmes: Implementation and Effectiveness Research-Postnatal Depression (SHAPER-PND) randomized controlled trial showed that Breathe Melodies for Mums (M4M), a 10-week community singing program for PND developed by the not-for-profit Breathe Arts Health Research, is both effective and feasible compared with an active control of community-based, non-musical mother-baby activities. To validate its scientific basis and refine its application, it is important to examine the biological mechanisms underlying these effects. This study investigated salivary cytokines and cortisol in mothers and their babies taking part in SHAPER-PND. Salivary samples (passive drool for cytokines, swabs for cortisol) were collected from the mother before and after the first (week 1) 1-hour M4M singing (or control) session. Additional samples were collected for cortisol: before and after the last (week 10) M4M singing (or control) session; and, at home, to assess awakening and diurnal cortisol rhythms in both mothers and infants, before and after the whole 10-week M4M singing (or control) intervention. In total, 145 participants (M4M group: 110, control group: 35) contributed data for biological analysis. Inflammatory cytokines were measured using the Meso Scale Discovery (MSD) proinflammatory panel, while cortisol was measured using the Salimetrics enzyme immunoassay kit. Only interleukin-1β (IL-1β), interleukin-6 (IL-6), IL-8 and tumour necrosis factor-alpha (TNF-α), were reliably detected in the saliva. During the week 1 session, IL-6 and TNF-α levels decreased only in the M4M group (IL-6: -26%, p < 0.001; TNF-α: -29%, p = 0.001), but not in the control group (all p values > 0.36), however a significant time x group interaction was seen only for IL-6 (p = 0.026). Cortisol levels fell in both groups at week 1 (control: -41%, p < 0.001, M4M: -22%, p < 0.001), but this effect was sustained only in the M4M group by week 10 (control: +4%, p = 0.19, M4M: -28%, p < 0.001). At home, infant evening cortisol levels decreased from Week 1 to Week 10 in the M4M group (-47%, p = 0.022) but not the control (-25%, p = 0.29). Moreover, the M4M group showed increased mother-infant cortisol synchrony at week 10 (p = 0.017), and closer mother-infant cortisol synchrony was associated with more infant-focused maternal speech (r(21) = -0.43, p = 0.039), less parent focused speech (r(26) = 0.58, p = 0.001), and less inattentive maternal engagement (r(21) = 0.51, p = 0.012)). These results demonstrate that participation in Breathe M4M is associated with acute reductions in stress-related biomarkers and in the regulation of infant stress physiology, which may mirror improvements in mother-infant communication.

6 December 2025 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
MKMadeline Kirkpatrick
Madeline Kirkpatrick
SASilvia Alboni
Silvia Alboni
FIFederico Imbeni
Federico Imbeni
NMNicole Mariani
Nicole Mariani
NTNuriza Tukiran
Nuriza Tukiran
ABAlessandra Borsini
Alessandra Borsini
Antenatal depression is linked to adverse neurodevelopmental outcomes in offspring, likely mediated by a multitude of biological mechanisms, including elevated maternal cytokines. However, factors modulating fetal vulnerability or resilience to inflammatory exposure remain unclear. This study examines whether the steroid hormone, oestradiol, can modulate inflammatory responses in an in vitro model of hippocampal neurogenesis, using two fetal hippocampal progenitor cell lines: female-derived HPC0A07/03C and male-derived HIP-009. Cells were pre-treated with oestradiol for 24- and 48-hours during proliferation, followed by interleukin-1beta (IL-1β) exposure prior to the initiation of differentiation. Markers of proliferation and neurogenesis, as well as inflammatory cytokines and kynurenine pathway metabolites, were assessed. In female HPC0A07/03C cells, oestradiol pre-treatment prevented IL-1β-induced proliferation and apoptosis, and reduced cytokine production. Conversely, in male HIP-009 cells, oestradiol pre-treatment did not prevent IL-1β-induced reduction of proliferation and apoptosis and indeed enhanced inflammatory responses after 48 h. In terms of differentiation, IL-1β produced opposite effects on neurogenesis across cell lines, increasing neuronal maturation in female HPC0A07/03C cells, but decreasing neurite complexity in male HIP-009 cells. Notably, oestradiol pre-treatment in both lines reduced neuronal differentiation and increased kynurenine levels, suggesting potentially detrimental long-term effects. These results highlight complex, potentially cell-line-dependent, sex-specific hormone-immune interactions shaping fetal neurodevelopment and underscore the need to investigate these interactions when assessing risks and developing therapeutic interventions for inflammation-related neurodevelopmental disorders.